Free Trial
→ Elon's new 'super startup' (From Banyan Hill Publishing) (Ad)tc pixel Free HEMO Stock Alerts

Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History

Hemogenyx Pharmaceuticals logo
GBX 679.50 -5.50 (-0.80%)
As of 05/15/2026 12:25 PM Eastern
Compare

Hemogenyx Pharmaceuticals Stock Price Performance

The Hemogenyx Pharmaceuticals (HEMO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 278.55%, with a year-to-date return of 17.56%. In the past month, the stock has decreased 25.82%, reflecting recent market activity.

As of the latest close, Hemogenyx Pharmaceuticals traded at GBX 679.50 with a market cap of £43.66 million and volume of 17,650 shares. Five years ago, the stock traded at GBX 2.25, representing a 30,100.00% increase over that period. At the time, it had a market cap of £11.12 million and a volume of 4.41 million shares.

Receive HEMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+2.57%
1 Month
Performance
-25.82%
3 Month
Performance
-24.94%
Year-To-Date
Performance
+17.56%
1 Year
Performance
+278.55%
5 Year
Performance
+30,100.00%

HEMO Stock Chart for Saturday, May, 16, 2026

HEMO Chart by TradingView

Hemogenyx Pharmaceuticals Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
05/15/2026GBX 685GBX 679.50
-0.80%		GBX 698.86GBX 67017,650 shs£43.66 million
05/14/2026GBX 650GBX 685
+5.38%		GBX 689GBX 63031,030 shs£44.01 million
05/13/2026GBX 636GBX 650
+2.20%		GBX 650GBX 61513,230 shs£41.76 million
05/12/2026GBX 662.50GBX 636
-4.00%		GBX 684GBX 60243,491 shs£40.86 million
05/11/2026GBX 699GBX 662.50
-5.22%		GBX 699GBX 64015,088 shs£42.57 million
05/08/2026GBX 700GBX 699
-0.14%		GBX 699GBX 6605,573 shs£44.91 million
05/07/2026GBX 685GBX 700
+2.19%		GBX 700GBX 675.4642,172 shs£44.98 million
05/06/2026GBX 680GBX 685
+0.74%		GBX 699GBX 67019,331 shs£44.01 million
05/05/2026N/AGBX 680GBX 694GBX 66040,428 shs£43.69 million
04/30/2026GBX 680GBX 675
-0.74%		GBX 699GBX 66240,874 shs£43.37 million
04/29/2026GBX 690GBX 680
-1.45%		GBX 720GBX 66662,736 shs£43.69 million
04/28/2026GBX 803GBX 690
-14.07%		GBX 822GBX 680130,193 shs£44.33 million
04/27/2026GBX 806GBX 803
-0.37%		GBX 830GBX 7557,898 shs£51.59 million
04/24/2026GBX 814GBX 806
-0.98%		GBX 844GBX 74120,830 shs£51.79 million
04/23/2026GBX 804GBX 814
+1.24%		GBX 847GBX 68142,488 shs£52.30 million
04/22/2026GBX 860GBX 804
-6.51%		GBX 908GBX 800.247,272 shs£51.66 million
04/21/2026GBX 794GBX 860
+8.31%		GBX 888GBX 82113,128 shs£55.26 million
04/20/2026GBX 900GBX 794
-11.78%		GBX 907GBX 7948,802 shs£51.01 million
04/17/2026GBX 916GBX 900
-1.75%		GBX 940GBX 83131,290 shs£57.83 million
04/16/2026GBX 880GBX 916
+4.09%		GBX 919GBX 876.847,389 shs£58.85 million
04/15/2026GBX 865GBX 880
+1.73%		GBX 959GBX 826.0614,062 shs£56.54 million
Related Companies

This page (LON:HEMO) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Secret behind near perfectly timed stock trades…?
After 20 years of professional trading, Ross Givens says this is the single most lucrative market strategy he ...
Traders Agency | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
The gold strategy that works whether prices rise or fall
Former $900 million hedge fund manager Larry Benedict has developed a strategy he calls Gold Skimming - a way ...
Brownstone Research | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
The NASTY TRUTH about the SpaceX IPO
In nearly every major IPO, roughly 95% of the gains are captured before retail investors can place a trade. It...
The Oxford Club | Sponsoredtc pixel